[Risk to the newborn infant following premature rupture of fetal membranes].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000517:prevention & control*; D002821:Chorioamnionitis / Q000517:prevention & control; D004359:Drug Therapy, Combination; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000150:complications*; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D012306:Risk; D018805:Sepsis / Q000517:prevention & control; D013203:Staphylococcal Infections / Q000517:prevention & control; D013290:Streptococcal Infections / Q000517:prevention & control
D000900:Anti-Bacterial Agents
Die Gefährdung des Neugeborenen nach vorzeitigem Blasensprung.